Somewhere in the last eighteen months, the content moved faster than the conscience. AI-generated health content is now being published, shared, and acted on at a scale no medical reviewer, no compliance team, and no platform algorithm was built to handle — and the biopharma industry is still debating its AI content policy while patients make treatment decisions based on posts no human wrote and no expert verified. This session doesn't ask whether AI belongs in healthcare influence. That debate is over. It asks the question the room has been avoiding: now that the machine can produce medically plausible content at infinite scale, who exactly is responsible when it's wrong? Challenging the comfortable assumption that good intent and strong guidelines are enough, this talk maps the gap between the speed of AI content generation and the speed of human verification — and names it for what it is: the most consequential trust problem the industry has ever created for itself. Attendees will leave not with a policy checklist, but with a sharper sense of urgency — and a clear-eyed view of what it will actually take to close the gap before a patient pays the price.
